• Home
• Defective Drug Index
• About A Drug Recall
• Contact A Defective Drug Lawyer

We Can Help.

Bextra Reaction

The American Heart Association convened for their annual meeting on November 9, 2004. Among the major presentation topics was talk about the potential adverse Bextra reaction that has been shown to occur in certain Bextra users. A leading heart researcher at the convention announced a study revealing that patients who had recently undergone cardiac bypass surgery were more likely to experience an adverse Bextra reaction than patients who were not taking this medication. Patients taking Bextra were twice as likely to suffer a heart attack or stroke as patients who were not.

The New York Times published an article indicating that serious cardiovascular complications were associated with the use of Bextra in certain patient populations. Pfizer, the pharmaceutical company who manufactures Bextra, announced that the company has plans to conduct further research about this adverse Bextra reaction, but that a Bextra recall would not be considered at this time.

Patients who had undergone heart surgery in this particular trial were much more likely to experience adverse health complications as a result of a Bextra reaction. As compared to patients not taking Bextra, the Bextra reaction in users included an increased occurrence of heart attack, stroke, renal failure, and wound complications. No conclusive studies have revealed cardiovascular Bextra reaction risks in other patient groups.

Other types of serious Bextra reaction risks have been extensively researched and well documented since this drug was first approved for use in the United States. The most common adverse Bextra reaction symptoms include indigestion, headache, abdominal pain, nausea, and diarrhea. An adverse Bextra reaction can also occur in patients who are concurrently taking other popular medications such as aspirin, Warfarin, and oral contraceptives. An allergic or anaphylactic Bextra reaction is also possible in patients taking this prescription pain medication.

The most serious type of Bextra reaction that can occur in patients involves the risk of developing serious skin conditions. An adverse Bextra reaction can cause Stevens-Johnson syndrome or toxic epidermal necrolysis. Both of these Bextra reaction skin conditions have led to fatality in Bextra patients. Stevens-Johnson syndrome is a Bextra reaction characterized by a severe inflammatory eruption of the skin and mucous membranes. A toxic epidermal necrolysis Bextra reaction causes large portions of a patient's skin to become irritated, red, and peel much like a second degree burn would.

Because there is a significant possibility that a patient can suffer a serious adverse Bextra reaction causing cardiovascular injury, drug interactions, allergic reactions, and severe skin conditions, patients who are taking this drug should be carefully monitored for any sign of complications. If a patient experiences any adverse Bextra reaction symptoms they should be evaluated by a medical professional as soon as possible.

If you have been injured because of an adverse Bextra reaction, you may wish to contact a Bextra Lawyer who may be able to help you recover what you have lost as a result of your injuries.

More Bextra Resources

Bextra Consumer Information - Patient FAQ on Bextra, including side effects, warnings and drug information from the FDA.

• Plavix Side Effects
• Fosamax Side Effects
• Paxil Birth Defect
• Trasylol Lawyer
• Viagra Blindness
• Ortho Evra Attorneys